Consequently, the objective of this study was to assess NRP2 and its ligand SEMA3F as potential biomarkers for patient survival and their ability to predict lymph node metastases in esophageal adenocarcinoma. The gene discussed is SEMA3F; the disease is metastatic malignant neoplasm in the lymph nodes.